Trial intelligence / Profile preview

Oral Sedation During Cervical Dilator Placement

NCT03202550Phase 4Completed

Sponsor
Johns Hopkins University
Start
Jun 2017
Primary completion
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of lorazepam and oxycodone in procedural pain (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Cervical Dilator Placement Pain. Started Jun 2017; status: completed.

02

Drugs

lorazepamoxycodone
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT03202550.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03202550.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call